Could a genetic biomarker predict your risk for severe food allergies?

Researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago have identified a genetic biomarker, α-tryptase, that may predict the severity of food allergy reactions. This discovery opens the door for new treatment strategies and offers a way to distinguish patients at risk for severe reactions.

Radiometer celebrates 70 years in acute care diagnostics

In 1954, Radiometer launched the world’s first commercially available blood gas analyzer. This event catapulted a small Danish company that produced devices for the radio

July 1, 2024

Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis – Biotech Investments

EQS-News: Imcyse SA / Key word(s): Miscellaneous Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with

June 23, 2023

FDA Reviewers Say OTC Decongestant Doesn’t Work

When pseudoephedrine moved “behind-the-counter” nearly 20 years ago, it left oral phenylephrine (with brands including Sudafed PE and Suphedrine PE) as the only nasal decongestant

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.